×

Consolidated Cash Flow Statement

for the year ended March 31, 2024

in ‘000s
    Year ended
31.03.2024
Year ended
31.03.2023
Cash flow from/(used in) operating activities      
Profit/(loss) before taxes   596,839,961 458,300,782
Adjustments for:      
Depreciation and amortisation   19,958,856 16,351,038
Net (appreciation)/depreciation on investments   16,172,037 27,053,455
Provision in respect of non-performing and other assets   9,635,716 (3,653,501)
General provision for standard assets   11,658,491 4,898,941
Provision for contingencies & others   8,780,202 54,236,861
(Profit)/loss on sale of fixed assets   (144,093) (542,579)
Employees stock options expense   7,029,081 5,180,508
  (i) 669,930,251 561,825,505
Adjustments for:      
(Increase)/decrease in investments   167,355,354 (158,286,285)
(Increase)/decrease in advances   (1,782,646,848) (1,638,931,648)
Increase/(decrease) in deposits   2,329,930,107 1,194,663,589
(Increase)/decrease in other assets   18,818,794 (165,971,353)
Increase/(decrease) in other liabilities and provisions   302,893,172 277,742,529
  (ii) 1,036,350,579 (490,783,168)
Refund/(payment) of direct taxes (iii) (133,436,047) (108,754,258)
Net cash flow from/(used in) operating activities (i)+(ii)+(iii) (A) 1,572,844,783 (37,711,921)
Cash flow from/(used in) investing activities      
Purchase of fixed assets   (36,785,464) (24,676,808)
Proceeds from sale of fixed assets   698,893 2,874,176
(Purchase)/sale of held to maturity securities   (1,423,224,353) (658,250,590)
Net cash flow from/(used in) investing activities (B) (1,459,310,924) (680,053,222)
Cash flow from/(used in) financing activities      
Proceeds from issue of share capital (including ESOPs)   11,708,675 9,420,691
Proceeds from long-term borrowings   391,968,191 417,361,966
Repayment of long-term borrowings   (391,468,771) (268,917,978)
Net proceeds/(repayment) of short-term borrowings   181,423,005 124,836,960
Dividend paid   (55,985,964) (34,794,463)
Net cash flow from/(used in) financing activities (C) 137,645,136 247,907,176
Effect of exchange fluctuation on translation reserve (D) 4,234,435 3,163,063
Net increase/(decrease) in cash and cash equivalents (A) + (B) + (C) + (D)   255,413,430 (466,694,904)
Cash and cash equivalents at beginning of the year   1,364,564,928 1,831,259,832
Add: Addition of ICICI Lombard General Insurance Company
Limited and I-Process Services (India) Private Limited as a
subsidiary in consolidation during the year
  7,710,668 -
Cash and cash equivalents at end of the year   1,627,689,026 1,364,564,928

1. Cash and cash equivalents include cash in hand, foreign currency notes, balances with RBI, balances with other banks and money at call and short notice.

As per our Report of even date.

For M S K A & Associates
Chartered Accountants
ICAI Firm Registration no.:
105047W

Tushar Kurani
Partner
Membership no.: 118580

For KKC & Associates LLP
Chartered Accountants
ICAI Firm Registration no.:
105146W/W100621

Vinit Jain
Partner
Membership no.: 145911

For and on behalf of the Board of Directors

Girish Chandra Chaturvedi
Chairman
DIN-00110996
 

Rakesh Jha
Executive Director
DIN-00042075

Anindya Banerjee
Group Chief Financial Officer

Uday M. Chitale
Director
DIN-00043268
 

Sandeep Batra
Executive Director
DIN-03620913

Prachiti Lalingkar
Company Secretary

Sandeep Bakhshi
Managing Director & CEO
DIN-00109206
 

Ajay Kumar Gupta
Executive Director
DIN-07580795

Rajendra Khandelwal
Chief Accountant

Mumbai
April 27, 2024